AlphaStocks
5.5
Consider Buy

Medtronic plc (MDT)

As of Sep 19, 2026, Medtronic plc (MDT) scores 5.5/10 on AlphaStocks' five-model composite, #75 of 168 Health Care stocks. At $92, MDT trades 11% below its model fair value of $103.

Health Care / Health Care Equipment

S&P 500

$92.13

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 19, 2026

#75out of 168 in Health Care

Is Medtronic plc a Good Investment in 2026?

Medtronic plc (MDT) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Medtronic plc as Strong (7/9). The Lynch model is the least favorable, rating it Neutral. Medtronic plc currently trades 11% below its estimated fair value of $103. Medtronic plc ranks #75 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.7ROE9.8Market Cap118BDiv Yield3.6

Estimated Fair Value

$103.0011% below

Trading below estimated fair value. P/E of 25x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

40% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Strong

Earnings yield 8.5% · ROC 43%

Frequently Asked Questions

Is Medtronic plc (MDT) a good investment?
As of Sep 19, 2026, Medtronic plc (MDT) scores 5.5/10 on AlphaStocks' five-model composite, #75 of 168 Health Care stocks. At $92, MDT trades 11% below its model fair value of $103. That is a middle-of-the-pack score with no strong signal either way.
What is Medtronic plc's Piotroski F-Score?
Medtronic plc's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MDT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $103, MDT appears undervalued. The stock currently trades 11% below its estimated fair value. Trading below estimated fair value. P/E of 25x is moderate for this quality level.
How does MDT compare to other Health Care stocks?
Medtronic plc ranks #75 out of 168 stocks in the Health Care sector, placing it in the top 45% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about MDT?
AlphaStocks evaluates MDT using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.5/10.

Similar Stocks

INSPUFPTBDX

Compare MDT with

INSP vs MDTMDT vs UFPTBDX vs MDTABT vs MDT

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer